Sewon Cellontech Co., Ltd.   Report issue

For profit Phase 3 Phase 4
Founded: Seoul Korea, Republic of (1971)
Status: No NME R&D (1971)

Organization Overview

First Clinical Trial
2010
NCT02537067
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (1)

collagen (1 trial)

Drugs in Phase 3 Trials (1)

chondroitin (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Fasciitis (Phase 4)

Fasciitis, Plantar (Phase 4)

Joint Diseases (Phase 3)

Osteoarthritis (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 2